SOLB Stock Overview
Solvay SA provides advanced materials and specialty chemicals worldwide.
No risks detected for SOLB from our risk checks.
Price History & Performance
|Historical stock prices|
|Current Share Price||€89.68|
|52 Week High||€118.65|
|52 Week Low||€78.00|
|1 Month Change||1.20%|
|3 Month Change||-9.45%|
|1 Year Change||-17.95%|
|3 Year Change||6.03%|
|5 Year Change||-22.96%|
|Change since IPO||223.00%|
Recent News & Updates
|SOLB||BE Chemicals||BE Market|
Return vs Industry: SOLB matched the Belgian Chemicals industry which returned -17.3% over the past year.
Return vs Market: SOLB underperformed the Belgian Market which returned -5.1% over the past year.
|SOLB Average Weekly Movement||6.0%|
|Chemicals Industry Average Movement||5.0%|
|Market Average Movement||4.8%|
|10% most volatile stocks in BE Market||7.8%|
|10% least volatile stocks in BE Market||2.8%|
Stable Share Price: SOLB is not significantly more volatile than the rest of Belgian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: SOLB's weekly volatility (6%) has been stable over the past year.
About the Company
Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aircraft, and healthcare industries; and composite materials for aerospace engineered materials market.
Solvay Fundamentals Summary
|SOLB fundamental statistics|
Is SOLB overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SOLB income statement (TTM)|
|Cost of Revenue||€9.44b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||11.35|
|Net Profit Margin||9.39%|
How did SOLB perform over the long term?See historical performance and comparison
4.3%Current Dividend Yield
Is Solvay undervalued compared to its fair value and its price relative to the market?
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SOLB (€89.68) is trading below our estimate of fair value (€174.38)
Significantly Below Fair Value: SOLB is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: SOLB is poor value based on its Price-To-Earnings Ratio (7.9x) compared to the Belgian Chemicals industry average (7.5x).
PE vs Market: SOLB is good value based on its Price-To-Earnings Ratio (7.9x) compared to the Belgian market (11.6x).
Price to Earnings Growth Ratio
PEG Ratio: SOLB is poor value based on its PEG Ratio (3.3x)
Price to Book Ratio
PB vs Industry: SOLB is good value based on its Price-To-Book Ratio (1x) compared to the BE Chemicals industry average (2.3x).
How is Solvay forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SOLB's forecast earnings growth (2.4% per year) is above the savings rate (1.1%).
Earnings vs Market: SOLB's earnings (2.4% per year) are forecast to grow slower than the Belgian market (15.4% per year).
High Growth Earnings: SOLB's earnings are forecast to grow, but not significantly.
Revenue vs Market: SOLB's revenue (1.8% per year) is forecast to grow faster than the Belgian market (1% per year).
High Growth Revenue: SOLB's revenue (1.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SOLB's Return on Equity is forecast to be low in 3 years time (11.2%).
How has Solvay performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SOLB has high quality earnings.
Growing Profit Margin: SOLB became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: SOLB's earnings have declined by 23.1% per year over the past 5 years.
Accelerating Growth: SOLB has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: SOLB has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (53.1%).
Return on Equity
High ROE: SOLB's Return on Equity (12.7%) is considered low.
How is Solvay's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: SOLB's short term assets (€8.5B) exceed its short term liabilities (€6.6B).
Long Term Liabilities: SOLB's short term assets (€8.5B) exceed its long term liabilities (€5.7B).
Debt to Equity History and Analysis
Debt Level: SOLB's net debt to equity ratio (22.3%) is considered satisfactory.
Reducing Debt: SOLB's debt to equity ratio has reduced from 52.1% to 36.6% over the past 5 years.
Debt Coverage: SOLB's debt is well covered by operating cash flow (44.9%).
Interest Coverage: SOLB's interest payments on its debt are well covered by EBIT (15.5x coverage).
What is Solvay current dividend yield, its reliability and sustainability?
Dividend Score 5/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: SOLB's dividend (4.29%) is higher than the bottom 25% of dividend payers in the Belgian market (1.76%).
High Dividend: SOLB's dividend (4.29%) is low compared to the top 25% of dividend payers in the Belgian market (5.76%).
Stability and Growth of Payments
Stable Dividend: SOLB's dividends per share have been stable in the past 10 years.
Growing Dividend: SOLB's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (33.9%), SOLB's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (44.5%), SOLB's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ilham Kadri (52 yo)
Dr. Ilham Kadri has been Chief Executive Officer and Non independent Director at Solvay SA since March 1, 2019. Dr. Kadri was an Executive Officer of Solvay SA since January 1, 2019 until March 1, 2019. Sh...
CEO Compensation Analysis
Compensation vs Market: Ilham's total compensation ($USD4.38M) is above average for companies of similar size in the Belgian market ($USD2.23M).
Compensation vs Earnings: Ilham's compensation has been consistent with company performance over the past year.
Experienced Management: SOLB's management team is considered experienced (3.3 years average tenure).
Experienced Board: SOLB's board of directors are considered experienced (8.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Solvay SA's employee growth, exchange listings and data sources
- Name: Solvay SA
- Ticker: SOLB
- Exchange: ENXTBR
- Founded: 1863
- Industry: Diversified Chemicals
- Sector: Materials
- Implied Market Cap: €9.294b
- Shares outstanding: 103.64m
- Website: https://www.solvay.com
Number of Employees
- Solvay SA
- Rue de Ransbeek, 310
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/25 00:00|
|End of Day Share Price||2022/05/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.